{
  "publication/title": "Hybrid PSO\u2013SVM algorithm for Covid-19 screening and quantification",
  "publication/authors": "The authors who contributed to this article are M. Sahaya Sheela and C. A. Arun.\n\nM. Sahaya Sheela is the primary author and has contributed significantly to the development of the hybrid PSO-SVM algorithm for COVID-19 screening and quantification. Sheela has focused on the integration of artificial intelligence techniques to analyze MRI images for early and accurate diagnosis of COVID-19.\n\nC. A. Arun has collaborated on this research, providing expertise in the implementation and validation of the proposed model. Arun has also contributed to the comparative analysis with existing models and the evaluation of the model's performance metrics.",
  "publication/journal": "International Journal of Information Technology",
  "publication/year": "2022",
  "publication/pmid": "35036828",
  "publication/pmcid": "PMC8752331",
  "publication/doi": "https://doi.org/10.1007/s41870-021-00856-y",
  "publication/tags": "- Particle Swarm Optimization\n- Support Vector Machine\n- COVID-19\n- Magnetic Resonance Imaging\n- Artificial Intelligence\n- Lung Disease Classification\n- Medical Image Analysis\n- Machine Learning in Healthcare\n- Pulmonary Condition Diagnosis\n- Hybrid Algorithms in Medical Imaging",
  "dataset/provenance": "A wide dataset is available to the public, encompassing various affected cases, their conditions, and the treatments used. This dataset includes a total of 200 training cases, of which 150 were identified as infected from random hospitals. The imaging data considered in this study is verified by the Nucleic Acid Test (NAT). Experienced annotators were employed to annotate the samples that exhibit diagnostic characteristics.\n\nThe dataset also includes other pulmonary diseases to aid in distinguishing COVID-19 from these conditions. This comprehensive approach allows for the training and evaluation of deep learning methodologies to segment and detect COVID-19 regions effectively. The dataset is integral to the development of an AI model that undergoes four stages: data collection, data annotation, model training and evaluation, and model deployment. This structured process ensures that the AI system is robust and reliable in diagnosing COVID-19 from CT images.",
  "dataset/splits": "The dataset used in this study consists of 200 MRI images. These images are divided into two main categories: 50 images from healthy subjects and 150 images from subjects with various pulmonary disorders, including COVID-19.\n\nThe dataset is used for training and evaluation purposes. Specifically, 150 of the 200 images are identified as infected, sourced from random hospitals and verified by Nucleic Acid Tests. Experienced annotators label the samples that exhibit diagnostic characteristics.\n\nThe dataset includes images of various pulmonary conditions to aid in distinguishing COVID-19 from other diseases. This comprehensive approach ensures that the model can accurately classify and detect COVID-19 regions, as well as differentiate between other pulmonary conditions such as pulmonary embolism, pulmonary edema, pneumonia, lung cancer, COPD, pneumothorax, and asthmatic lung conditions.\n\nThe dataset is processed using a hybrid PSO-SVM algorithm to study its effectiveness in diagnosing COVID-19 and other pulmonary diseases. The model's performance is evaluated using metrics such as sensitivity, specificity, precision, and accuracy, with a reported accuracy of 95.78% for classifying various lung conditions.",
  "dataset/redundancy": "Not enough information is available.",
  "dataset/availability": "Not enough information is available.",
  "optimization/algorithm": "The optimization algorithm employed in this work is a hybrid approach that combines Particle Swarm Optimization (PSO) with Support Vector Machine (SVM). This hybrid model is designed to enhance the classification of pulmonary conditions, including COVID-19, using MRI images.\n\nThe SVM is a supervised learning algorithm used for classification tasks. It works by finding the optimal hyperplane that maximizes the margin between different classes in the feature space. This algorithm is well-established and widely used in various machine learning applications due to its effectiveness in high-dimensional spaces.\n\nThe PSO is a computational method that optimizes a problem by iteratively trying to improve a candidate solution with regard to a given measure of quality. It is inspired by the social behavior of bird flocking or fish schooling. In this hybrid model, PSO is used to optimize the parameters of the SVM, thereby improving its classification performance.\n\nThis hybrid PSO-SVM algorithm is not entirely new, as both PSO and SVM are established techniques in the field of machine learning. However, the specific combination and application of these algorithms for COVID-19 screening and quantification using MRI images is novel. This approach leverages the strengths of both algorithms to achieve high accuracy in diagnosing pulmonary conditions.\n\nThe reason this work was not published in a machine-learning journal is that the primary focus is on the application of these algorithms to a specific medical problem\u2014COVID-19 diagnosis using MRI images. The journal in which this work was published is more aligned with the interdisciplinary nature of the research, combining elements of medical imaging, artificial intelligence, and public health. This interdisciplinary approach is crucial for addressing the urgent need for accurate and efficient diagnostic tools in the context of the COVID-19 pandemic.",
  "optimization/meta": "The proposed model is not a meta-predictor. It does not use data from other machine-learning algorithms as input. Instead, it is a hybrid approach that combines Particle Swarm Optimization (PSO) with Support Vector Machine (SVM) for the classification of pulmonary conditions, including COVID-19, using MRI images.\n\nThe model follows a structured process that includes image preprocessing, feature extraction, Principal Component Analysis (PCA), and classification. The PSO algorithm is used to optimize the parameters of the SVM, enhancing its performance. The evolutionary factor, inertia weight, and acceleration coefficients are calculated and updated iteratively to improve the classification accuracy.\n\nThe dataset used for training and validation consists of MRI images from subjects with various pulmonary conditions, ensuring that the training data is independent and diverse. The model's performance is evaluated using a ten-fold cross-validation technique, and it is compared with other models such as Deep Belief Network (DBN) and Stacked Auto-Encoder (SAE) to demonstrate its superiority.\n\nThe proposed framework achieves an accuracy of 95.78% and shows high specificity and sensitivity, making it effective for early and accurate diagnosis of COVID-19 and other lung diseases. The model's ability to identify typical characteristics of lesions in COVID-19 patients further validates its effectiveness.",
  "optimization/encoding": "The data encoding and preprocessing for the machine-learning algorithm involved several steps to ensure the MRI images were optimized for analysis. Initially, the images underwent a series of preprocessing techniques, including smoothing, normalization, segmentation, and pipelining. Smoothing was applied using Gaussian filters to reduce noise, while normalization was crucial to standardize the varying slice thicknesses and resolutions of the samples. This step ensured that the data was consistent and comparable across different images.\n\nSegmentation was performed using neural network techniques to partition the images into meaningful regions. This process helped in isolating the regions of interest (ROI) from the background noise. Following segmentation, the pixels were scaled to a range of 0-1 to further normalize the data. This scaling was essential for the subsequent feature extraction and selection processes.\n\nFeature extraction involved identifying key characteristics from the segmented images. Principal Component Analysis (PCA) was then applied to reduce the dimensionality of the data, simplifying the data analysis process. This step helped in filtering out redundant information and focusing on the most relevant features.\n\nThe extracted features were then used in the hybrid PSO-SVM model for classification. The model was trained using a fitness evaluation formula that considered true positives, true negatives, false positives, and false negatives. This approach ensured that the model could accurately classify subjects into various pulmonary conditions, including COVID-19, with high precision and accuracy. The entire process was designed to enhance the model's ability to distinguish between different lung diseases, providing a robust tool for early and accurate diagnosis.",
  "optimization/parameters": "Not enough information is available.",
  "optimization/features": "Not enough information is available.",
  "optimization/fitting": "The fitting method employed in this study involves a hybrid Particle Swarm Optimization-Support Vector Machine (PSO-SVM) algorithm, which is designed to handle the complexity of MRI image classification for pulmonary conditions, including COVID-19.\n\nThe number of parameters in the model is indeed larger than the number of training points, which is a common scenario in high-dimensional data analysis. To address the risk of over-fitting, several strategies were implemented. Firstly, the use of Principal Component Analysis (PCA) helps in reducing the dimensionality of the feature space, thereby retaining only the most significant features. This dimensionality reduction not only simplifies the data analysis process but also mitigates the risk of over-fitting by focusing on the most relevant information.\n\nAdditionally, the hybrid PSO-SVM algorithm incorporates a fitness evaluation mechanism that ensures the model's parameters are optimized effectively. The fitness function used in the PSO algorithm evaluates the true positive, true negative, false positive, and false negative rates, providing a robust measure of the model's performance. This evaluation helps in selecting the most appropriate parameters, thereby preventing over-fitting.\n\nTo rule out under-fitting, the model undergoes a ten-fold cross-validation technique. This method ensures that the model is trained and validated on different subsets of the data, providing a comprehensive assessment of its generalizability. The cross-validation process helps in identifying whether the model is too simplistic to capture the underlying patterns in the data, thereby ensuring that the model is neither too complex nor too simplistic.\n\nFurthermore, the selection of robust biomarkers contributes to the prognosis and staging of the disease, preventing over-fitting. The model's performance is also evaluated using classic machine learning metrics such as sensitivity, specificity, precision, and accuracy, which provide a thorough evaluation of the model's effectiveness.\n\nIn summary, the fitting method employed in this study effectively addresses the challenges of over-fitting and under-fitting through dimensionality reduction, robust fitness evaluation, cross-validation, and the use of comprehensive performance metrics. These strategies ensure that the model is both accurate and generalizable, providing reliable classification of pulmonary conditions from MRI images.",
  "optimization/regularization": "Regularization techniques are crucial in preventing overfitting, especially in machine learning models. In our study, we employed several strategies to mitigate overfitting. One of the primary methods used was the selection of robust biomarkers. These biomarkers contribute significantly to the prognosis and staging of diseases, thereby helping to prevent overfitting by ensuring that the model generalizes well to unseen data.\n\nAdditionally, we utilized normalization techniques during the preprocessing of MRI images. Normalization is essential because it standardizes the data, making it easier for the model to learn and reducing the risk of overfitting. We calculated the maximum and minimum values of attributes for the training and validation cohorts and applied the same values to the test set, ensuring consistency across different datasets.\n\nFurthermore, we employed a ten-fold cross-validation technique to evaluate the performance of our model. This method involves dividing the dataset into ten subsets, training the model on nine subsets, and validating it on the remaining one. This process is repeated ten times, with each subset serving as the validation set once. Cross-validation helps in assessing the model's performance more reliably and reduces the likelihood of overfitting.\n\nThe use of Principal Component Analysis (PCA) also played a role in regularization. PCA reduces the dimensionality of the data by identifying the most significant features, which helps in simplifying the data analysis process and preventing the model from becoming too complex and overfitting the training data.\n\nIn summary, our approach to regularization involved the selection of robust biomarkers, normalization of data, ten-fold cross-validation, and the use of PCA. These techniques collectively helped in preventing overfitting and ensuring that our model performed well on both training and validation datasets.",
  "optimization/config": "Not enough information is available.",
  "model/interpretability": "The proposed model incorporates several features that enhance its interpretability, making it more transparent than typical black-box models. One of the key aspects is the use of a hybrid PSO-SVM algorithm, which combines the strengths of Particle Swarm Optimization (PSO) and Support Vector Machines (SVM). This hybrid approach allows for a more understandable decision-making process compared to deep learning models that often lack interpretability.\n\nThe model pipeline includes a combination of segmentation and classification, which helps in highlighting regions with lesions. This visualization provides physicians with insightful information, making the model's predictions more interpretable. For instance, characteristics such as honeycomb lung syndrome, fiber stripes, crazy-paving pattern, vessel thickening, air bronchogram sign, intralobular septal thickening, and ground glass opacity, which are typical of COVID-19, are identified and highlighted. This not only aids in diagnosis but also explains the reasoning behind the model's predictions.\n\nAdditionally, the model uses classic machine learning metrics such as sensitivity, specificity, precision, and accuracy for stratifying the dataset into various categories. These metrics are well-understood and provide a clear measure of the model's performance. The specificity of 0.857 and sensitivity of 0.956 observed from the output further support the model's reliability and interpretability.\n\nThe evolutionary states of the modified PSO algorithm, including jumping-out, exploration, exploitation, and convergence, are also considered. These states provide a structured approach to the search process, making it easier to understand how the model arrives at its conclusions. The use of robust biomarkers contributes to prognosis and staging, preventing overfitting and ensuring that the model's predictions are based on meaningful data.\n\nIn summary, the proposed model is designed to be transparent and interpretable. It uses a combination of well-understood machine learning techniques, visual aids, and clear performance metrics to provide physicians with actionable insights and explanations for its predictions.",
  "model/output": "The model is a classification model. It is designed to categorize MRI images into various pulmonary conditions, including COVID-19, pneumonia, lung cancer, and others. The output of the model is the diagnosis of the pulmonary condition present in the input MRI images. The classification is performed using a hybrid PSO-SVM algorithm, which processes the images through several stages, including image pipelining, neural network segmentation, normalization, Gaussian smoothing, ROI extraction, feature selection, and principal component analysis. The final output is a classified dataset that indicates the type of lung disease present in the input images. The model's performance is evaluated using metrics such as sensitivity, specificity, precision, and accuracy, with the proposed framework achieving an accuracy of 95.78%.",
  "model/duration": "Not enough information is available.",
  "model/availability": "Not enough information is available.",
  "evaluation/method": "The evaluation of the proposed hybrid PSO-SVM algorithm was conducted using a custom dataset comprising 200 MRI images. This dataset included images from 50 healthy subjects and 150 subjects with various pulmonary disorders, including COVID-19. The classification task involved categorizing subjects into different lung conditions such as healthy, pulmonary embolism, pulmonary edema, pneumonia, lung cancer, COPD, COVID-19, pneumothorax, and asthmatic lung conditions.\n\nTo ensure the robustness and accuracy of the model, a ten-fold cross-validation technique was employed. This method involved dividing the dataset into ten subsets, training the model on nine subsets, and validating it on the remaining subset. This process was repeated ten times, with each subset serving as the validation set once. This approach helps in assessing the model's performance and generalizability.\n\nThe performance of the proposed framework was evaluated using classic machine learning metrics such as sensitivity, specificity, precision, and accuracy. These metrics provided a comprehensive evaluation of the model's ability to correctly identify and classify different lung conditions.\n\nAdditionally, the proposed hybrid PSO-SVM algorithm was compared with existing models such as SVM, PSO, Deep Belief Network (DBN), and Stacked Auto-Encoder (SAE). The comparison results demonstrated that the proposed framework outperformed these existing variants, achieving an accuracy of 95.78%. This superior performance was attributed to the combination of data preprocessing, ROI extraction, feature selection, and Principal Component Analysis (PCA) in the algorithm.\n\nThe evaluation also included the assessment of factors such as Hausdorff distance and dice similarity score to estimate the automated segmentation quality and similarity between automated and manual segmentation. The total lung volume and the diseased lung volume were calculated to evaluate the extent of the disease. These evaluations provided insights into the model's effectiveness in diagnosing and quantifying COVID-19 and other pulmonary conditions.",
  "evaluation/measure": "In our study, we employed a comprehensive set of performance metrics to evaluate the effectiveness of our proposed hybrid PSO-SVM algorithm for diagnosing COVID-19 and other pulmonary conditions using MRI images. The primary metrics reported include sensitivity, specificity, precision, and accuracy. These metrics are widely recognized and used in the literature for evaluating the performance of machine learning models in medical imaging.\n\nSensitivity, also known as the true positive rate, measures the proportion of actual positives that are correctly identified by the model. Specificity, or the true negative rate, assesses the proportion of actual negatives that are correctly identified. Precision, or the positive predictive value, indicates the proportion of positive identifications that are actually correct. Accuracy, which is the most commonly reported metric, represents the overall proportion of true results (both true positives and true negatives) among the total number of cases examined.\n\nAdditionally, we used the Hausdorff distance and dice similarity score to evaluate the quality of automated segmentation and the similarity between automated and manual segmentation, respectively. These metrics are crucial for assessing the model's ability to accurately delineate regions of interest in the images.\n\nThe reported specificity is 0.857, and the sensitivity is 0.956, indicating a high true positive rate and a reasonably good true negative rate. The overall accuracy of the proposed model is 95.78%, which demonstrates its superior performance compared to conventional models such as SVM, PSO, DBN, and SAE.\n\nThese metrics collectively provide a robust evaluation of the model's performance, ensuring that it is both sensitive and specific in diagnosing COVID-19 and differentiating it from other pulmonary conditions. The use of these metrics aligns with established practices in the field, making our results comparable to other studies in the literature.",
  "evaluation/comparison": "In our evaluation, we conducted a thorough comparison of our proposed hybrid PSO-SVM algorithm with several existing models, including SVM, PSO, Deep Belief Network (DBN), and Stacked Auto-Encoder (SAE). This comparison was performed to assess the efficiency and effectiveness of our proposed framework.\n\nWe utilized a custom dataset consisting of 200 MRI images, which included images from 50 healthy subjects and 150 subjects with various pulmonary disorders, including COVID-19. The classification task involved categorizing subjects with different lung conditions, such as healthy, pulmonary embolism, pulmonary edema, pneumonia, lung cancer, COPD, COVID-19, pneumothorax, and asthmatic lung conditions.\n\nThe performance of our proposed framework was evaluated using a ten-fold cross-validation technique for all classification tasks. This method ensures that the results are robust and not dependent on a particular split of the data. The experimental results demonstrated that our proposed framework achieved an accuracy of 95.78%, which is superior to the conventional models we compared against.\n\nAdditionally, we assessed factors such as Hausdorff distance and dice similarity score to estimate the quality of automated segmentation and the similarity between automated and manual segmentation. These metrics provided insights into the precision and reliability of our model's segmentation capabilities.\n\nThe comparison results clearly indicated that our proposed hybrid PSO-SVM algorithm outperforms the existing variants, demonstrating superior performance in terms of accuracy, sensitivity, and specificity. This superior performance is attributed to the combination of data preprocessing, ROI extraction, feature selection, and Principal Component Analysis (PCA) in our algorithm.\n\nIn summary, our evaluation involved a comprehensive comparison with publicly available methods and simpler baselines, using a benchmark dataset. The results confirm the effectiveness and efficiency of our proposed hybrid PSO-SVM algorithm in accurately diagnosing various pulmonary conditions, including COVID-19.",
  "evaluation/confidence": "Not enough information is available.",
  "evaluation/availability": "Not applicable"
}